First Eagle Investment Management LLC Invests $3.38 Million in Quanterix Corporation $QTRX

Posted by Francis Steltz on May 14th, 2026

First Eagle Investment Management LLC acquired a new stake in Quanterix Corporation (NASDAQ:QTRX – Free Report) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 531,427 shares of the company’s stock, valued at approximately $3,380,000.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Farther Finance Advisors LLC acquired a new position in Quanterix during the 4th quarter worth about $26,000. Quarry LP grew its position in Quanterix by 277,300.0% in the 3rd quarter. Quarry LP now owns 5,548 shares of the company’s stock valued at $30,000 after acquiring an additional 5,546 shares in the last quarter. R Squared Ltd acquired a new position in Quanterix in the 3rd quarter valued at about $64,000. HUB Investment Partners LLC purchased a new stake in Quanterix during the second quarter worth about $81,000. Finally, Brevan Howard Capital Management LP purchased a new stake in Quanterix during the second quarter worth about $96,000. Hedge funds and other institutional investors own 86.48% of the company’s stock.

Quanterix Price Performance

QTRX stock opened at $2.88 on Thursday. The business’s 50-day moving average is $3.82 and its two-hundred day moving average is $5.51. The firm has a market capitalization of $135.68 million, a P/E ratio of -1.22 and a beta of 1.15. Quanterix Corporation has a 1 year low of $2.56 and a 1 year high of $8.77.

Quanterix (NASDAQ:QTRX – Get Free Report) last announced its quarterly earnings data on Wednesday, May 6th. The company reported ($0.39) EPS for the quarter, topping analysts’ consensus estimates of ($0.51) by $0.12. Quanterix had a negative return on equity of 23.92% and a negative net margin of 71.86%.The business had revenue of $35.90 million during the quarter, compared to the consensus estimate of $36.84 million. On average, analysts expect that Quanterix Corporation will post -0.97 EPS for the current year.

Wall Street Analysts Forecast Growth

Several research analysts have recently commented on QTRX shares. TD Cowen lowered their price objective on shares of Quanterix from $7.00 to $4.00 and set a “hold” rating for the company in a research note on Thursday, May 7th. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Quanterix in a research note on Tuesday, April 21st. Canaccord Genuity Group decreased their price target on shares of Quanterix from $8.00 to $4.00 and set a “hold” rating for the company in a research report on Monday, April 20th. Finally, Wall Street Zen upgraded shares of Quanterix from a “sell” rating to a “hold” rating in a research note on Saturday, May 9th. Two investment analysts have rated the stock with a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the company currently has an average rating of “Reduce” and an average target price of $4.00.

View Our Latest Stock Analysis on Quanterix

Quanterix Company Profile

(Free Report)

Quanterix Corporation is a life sciences and diagnostics company specializing in ultra-sensitive digital immunoassay platforms. Its proprietary Single Molecule Array (Simoa) technology enables researchers to detect and quantify proteins, peptides and nucleic acids at femtomolar concentrations, offering sensitivity that surpasses traditional immunoassay methods. By translating single-molecule detection into routine laboratory workflows, Quanterix aims to accelerate biomarker discovery and the development of novel diagnostics and therapeutics.

The company’s core product portfolio includes the Simoa HD-1 and HD-X Analyzers, which automate high-throughput digital immunoassays for quantifying low-abundance biomarkers.